Browse

The Westlake-founded company specializes in non-opioid drugs that target sodium ion channels, and is now adding to what’s already been a busy month for the biotech IPO queue.

Medicare proposes to reduce payments to hospitals for certain drugs and imaging services.

A former doctor accused of sexual assault but on the run for 20 years appears to have been living a secret life as a biotech executive.